Published in Neurology on August 29, 2007
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA (2010) 8.93
Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol (2012) 4.47
The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause (2012) 4.04
Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers. J Clin Oncol (2009) 2.74
Accounting for bias due to selective attrition: the example of smoking and cognitive decline. Epidemiology (2012) 2.72
Risk factors for dementia with Lewy bodies: a case-control study. Neurology (2013) 2.38
Prophylactic oophorectomy in premenopausal women and long-term health. Menopause Int (2008) 2.26
Validation of the telephone interview for cognitive status-modified in subjects with normal cognition, mild cognitive impairment, or dementia. Neuroepidemiology (2009) 2.03
Increased cardiovascular mortality after early bilateral oophorectomy. Menopause (2009) 1.89
Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology (2013) 1.76
Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences. Clin Epidemiol (2014) 1.56
CKD associates with cognitive decline. J Am Soc Nephrol (2009) 1.55
Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation. J Neurosci (2009) 1.54
Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span. JAMA Neurol (2015) 1.52
Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer. Mayo Clin Proc (2010) 1.51
Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity. Brain Res (2010) 1.48
Estrogen-induced plasticity from cells to circuits: predictions for cognitive function. Trends Pharmacol Sci (2009) 1.47
Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res (2009) 1.47
Incidence, time trends, laterality, indications, and pathological findings of unilateral oophorectomy before menopause. Menopause (2014) 1.42
Online tool to guide decisions for BRCA1/2 mutation carriers. J Clin Oncol (2012) 1.35
Estrogen therapy and cognition: a review of the cholinergic hypothesis. Endocr Rev (2009) 1.33
Estrogen therapy: is time of initiation critical for neuroprotection? Nat Rev Endocrinol (2009) 1.29
Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases. Front Neuroendocrinol (2008) 1.23
Hormone therapy and cognitive function. Hum Reprod Update (2009) 1.22
Reproductive age modulates the impact of focal ischemia on the forebrain as well as the effects of estrogen treatment in female rats. Neurobiol Aging (2008) 1.20
Long-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging. Womens Health (Lond Engl) (2009) 1.16
Estradiol and cognitive function: past, present and future. Horm Behav (2014) 1.13
HIV, cognition and women. Neuropsychol Rev (2009) 1.11
Oophorectomy, menopause, estrogen, and cognitive aging: the timing hypothesis. Neurodegener Dis (2010) 1.11
Estrogen and cognitive functioning in women: lessons we have learned. Behav Neurosci (2011) 1.10
Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies. Menopause (2013) 1.08
Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD. Psychoneuroendocrinology (2010) 1.07
Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence. Biochim Biophys Acta (2010) 1.06
The long-term effects of oophorectomy on cognitive and motor aging are age dependent. Neurodegener Dis (2008) 1.06
Characteristics of hormone therapy, cognitive function, and dementia: the prospective 3C Study. Neurology (2009) 1.03
Estrogen neuroprotection and the critical period hypothesis. Front Neuroendocrinol (2011) 1.03
Presynaptic mitochondrial morphology in monkey prefrontal cortex correlates with working memory and is improved with estrogen treatment. Proc Natl Acad Sci U S A (2013) 1.03
Oophorectomy, estrogen, and dementia: a 2014 update. Mol Cell Endocrinol (2014) 1.02
Neurocognition and social skill in older persons with schizophrenia and major mood disorders: An analysis of gender and diagnosis effects. J Neurolinguistics (2010) 1.01
Hysterectomy, oophorectomy, estrogen, and the risk of dementia. Neurodegener Dis (2012) 1.01
Sex and gender differences in the causes of dementia: a narrative review. Maturitas (2014) 1.00
Ovarian hormone loss induces bioenergetic deficits and mitochondrial β-amyloid. Neurobiol Aging (2011) 0.97
Telephone interview for cognitive status (TICS) screening for clinical trials of physical activity and cognitive training: the seniors health and activity research program pilot (SHARP-P) study. Int J Geriatr Psychiatry (2011) 0.97
Increased mortality for neurological and mental diseases following early bilateral oophorectomy. Neuroepidemiology (2009) 0.97
Transitional versus surgical menopause in a rodent model: etiology of ovarian hormone loss impacts memory and the acetylcholine system. Endocrinology (2009) 0.96
Impairment of ovarian function and associated health-related abnormalities are attributable to low social status in premenopausal monkeys and not mitigated by a high-isoflavone soy diet. Hum Reprod (2010) 0.95
Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial. J Alzheimers Dis (2011) 0.95
BDNF upregulation rescues synaptic plasticity in middle-aged ovariectomized rats. Neurobiol Aging (2010) 0.95
Blood glutamate scavenging: insight into neuroprotection. Int J Mol Sci (2012) 0.95
Contemporary genetic technologies and female reproduction. Hum Reprod Update (2011) 0.95
Estrogen Effects on Cognitive and Synaptic Health Over the Lifecourse. Physiol Rev (2015) 0.95
Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers. Gynecol Oncol (2014) 0.94
Sex hormones modulate circulating antioxidant enzymes: impact of estrogen therapy. Redox Biol (2013) 0.94
Long-term health consequences of premature or early menopause and considerations for management. Climacteric (2015) 0.93
Cardiovascular Disease in Women: Clinical Perspectives. Circ Res (2016) 0.92
Effect of Ovarian Hormone Therapy on Cognition in the Aged Female Rhesus Macaque. J Neurosci (2016) 0.91
A simulation model to predict the impact of prophylactic surgery and screening on the life expectancy of BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2012) 0.91
Neuroscientists as cartographers: mapping the crossroads of gonadal hormones, memory and age using animal models. Molecules (2010) 0.90
Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury. Prog Neurobiol (2016) 0.90
The unique challenges of managing depression in mid-life women. World Psychiatry (2008) 0.89
Challenging and complex decisions in the management of the BRCA mutation carrier. J Womens Health (Larchmt) (2013) 0.89
Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause. J Steroid Biochem Mol Biol (2013) 0.89
An update on the cognitive impact of clinically-used hormone therapies in the female rat: models, mazes, and mechanisms. Brain Res (2013) 0.89
Premature menopause and risk of neurological disease: basic mechanisms and clinical implications. Mol Cell Endocrinol (2014) 0.89
Donepezil treatment restores the ability of estradiol to enhance cognitive performance in aged rats: evidence for the cholinergic basis of the critical period hypothesis. Horm Behav (2009) 0.89
Looking different, feeling different: women's reactions to risk-reducing breast and ovarian surgery. Fam Cancer (2012) 0.88
Genomic determinants of motor and cognitive outcomes in Parkinson's disease. Parkinsonism Relat Disord (2012) 0.87
Ovarian hormone deficiency reduces intrinsic excitability and abolishes acute estrogen sensitivity in hippocampal CA1 pyramidal neurons. J Neurosci (2011) 0.87
Hormone replacement therapy and risk for neurodegenerative diseases. Int J Alzheimers Dis (2012) 0.86
Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD. Bone Marrow Transplant (2014) 0.86
Do aromatase inhibitors have adverse effects on cognitive function? Breast Cancer Res (2011) 0.85
Gonadal hormones and cognitive aging: a midlife perspective. Womens Health (Lond Engl) (2011) 0.84
Oophorectomy: the debate between ovarian conservation and elective oophorectomy. Menopause (2013) 0.84
Estrogen regulation of Dkk1 and Wnt/β-Catenin signaling in neurodegenerative disease. Brain Res (2012) 0.84
Oestrogen signalling and neuroprotection in cerebral ischaemia. J Neuroendocrinol (2012) 0.83
Hypersensitivity of the hippocampal CA3 region to stress-induced neurodegeneration and amyloidogenesis in a rat model of surgical menopause. Brain (2013) 0.83
Risk of glaucoma after early bilateral oophorectomy. Menopause (2014) 0.83
Aging, estrogens, and episodic memory in women. Cogn Behav Neurol (2009) 0.83
Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on? Nat Rev Clin Oncol (2015) 0.83
Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause. Biol Sex Differ (2013) 0.83
Hypothalamic-pituitary-gonadal axis homeostasis predicts longevity. Age (Dordr) (2011) 0.83
Female reproductive factors, menopausal hormone use, and Parkinson's disease. Mov Disord (2013) 0.82
The cerebellum as a target for estrogen action. Front Neuroendocrinol (2012) 0.82
Gynecological history in chronic fatigue syndrome: a population-based case-control study. J Womens Health (Larchmt) (2010) 0.81
Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy. Fam Cancer (2012) 0.81
Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis. Neurology (2016) 0.80
Should surgical menopausal women be treated with estrogens to decrease the risk of dementia? Neurology (2007) 0.80
Menopausal hot flashes and white matter hyperintensities. Menopause (2016) 0.80
Ovarian hormone loss impairs excitatory synaptic transmission at hippocampal CA3-CA1 synapses. J Neurosci (2013) 0.80
Three midlife strategies to prevent cognitive impairment due to Alzheimer's disease. Climacteric (2014) 0.80
Ovariectomy results in variable changes in nociception, mood and depression in adult female rats. PLoS One (2014) 0.80
Adjuvant ovarian function suppression and cognitive function in women with breast cancer. Br J Cancer (2016) 0.79
Reassessing hysterectomy. Minn Med (2012) 0.79
Premature menopause: Hormone replacement therapy is indeed indicated. BMJ (2008) 0.79
Menopause, obesity and inflammation: interactive risk factors for Alzheimer's disease. Front Aging Neurosci (2015) 0.78
Ovarian Damage During chemotherapy in Autoimmune Diseases: Broad Health Implications beyond Fertility. Clin Med Insights Reprod Health (2012) 0.78
Estrogen Restores Multisynaptic Boutons in the Dorsolateral Prefrontal Cortex while Promoting Working Memory in Aged Rhesus Monkeys. J Neurosci (2016) 0.78
Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK. Fam Cancer (2015) 0.77
A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease Pathogenesis. J Alzheimers Dis (2015) 0.77
Postmenopausal hormone therapy and cognition. Horm Behav (2015) 0.77
The diagnosis of osteoporosis. J Bone Miner Res (1994) 10.90
Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med (1998) 9.43
Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med (1994) 9.25
Hip fractures in the elderly: a world-wide projection. Osteoporos Int (1992) 9.08
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51
Involutional osteoporosis. N Engl J Med (1986) 8.20
Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med (2000) 7.62
Psychotropic drug use and the risk of hip fracture. N Engl J Med (1987) 7.53
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone (1995) 5.76
Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54
Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med (1990) 5.49
Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) (1982) 5.29
A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. Am Rev Respir Dis (1992) 5.22
Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA (1996) 5.17
A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92
Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84
Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res (1992) 4.75
Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 4.74
Population-based study of survival after osteoporotic fractures. Am J Epidemiol (1993) 4.71
Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab (1998) 4.28
A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res (1998) 4.24
The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18
Surgical management of Meckel's diverticulum. An epidemiologic, population-based study. Ann Surg (1994) 4.16
Potential effect of authorization bias on medical record research. Mayo Clin Proc (1999) 4.01
Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology (1991) 3.90
The prevention and treatment of osteoporosis. N Engl J Med (1992) 3.90
Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain (2007) 3.82
Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest (1981) 3.60
Thoracic aortic aneurysms: a population-based study. Surgery (1982) 3.36
Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 3.34
Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet (1992) 3.30
Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08
Incidence of spontaneous pneumothorax in Olmsted County, Minnesota: 1950 to 1974. Am Rev Respir Dis (1979) 3.06
A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet (2004) 3.05
Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int (2011) 3.04
The role of radiotracer imaging in Parkinson disease. Neurology (2005) 3.02
Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med (1999) 2.98
Superficial siderosis. Neurology (2006) 2.98
Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation (1989) 2.94
Epidemiology of fractures of the proximal femur in Rochester, Minnesota. Clin Orthop Relat Res (1981) 2.93
Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest (1982) 2.92
Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89
Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum (1984) 2.85
Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology (1999) 2.81
Epidemiologic features of humeral fractures. Clin Orthop Relat Res (1982) 2.79
Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment. Mov Disord (1994) 2.77
Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med (2000) 2.77
Aversive properties of the negative stimulus in a successive discrimination. J Exp Anal Behav (1969) 2.75
Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75
Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int (2008) 2.74
Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int (2008) 2.72
Cognitive impairment after ECT in patients with Parkinson's disease and psychiatric illness. Am J Psychiatry (1992) 2.68
Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology (1999) 2.62
Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol (1992) 2.54
REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology (2010) 2.50
Long-term survival of a cohort of community residents with asthma. N Engl J Med (1994) 2.47
Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab (2001) 2.43
Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res (1999) 2.37
Osteoporosis and the risk of hip fracture. Am J Epidemiol (1986) 2.35
Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology (2000) 2.31
A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol (2000) 2.27
Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol (1989) 2.24
Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med (1982) 2.23
Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology (2007) 2.22
Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord (2000) 2.20
Comparison of multivariate tests for genetic linkage. Hum Hered (2001) 2.19
Evidence for two distinct syndromes of involutional osteoporosis. Am J Med (1983) 2.17
Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology (1992) 2.17
Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc (2001) 2.17
Incidence of Colles' fracture in a North American community. Am J Public Health (1982) 2.17
Outcomes of surgery in patients 90 years of age and older. JAMA (1989) 2.15
Isolated eyelid-opening apraxia: report of a new levodopa-responsive syndrome. Neurology (1994) 2.14
A family history of fracture and fracture risk: a meta-analysis. Bone (2004) 2.13
Selective peripheral denervation for torticollis: preliminary results. Mayo Clin Proc (1991) 2.12
Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology (1994) 2.12
Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 2.11
Trends in the utilization of primary total hip arthroplasty, 1969 through 1990: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc (1993) 2.10
Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome. Gastroenterology (1990) 2.09
Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study. Neurology (2009) 2.09
alpha-Synuclein gene haplotypes are associated with Parkinson's disease. Hum Mol Genet (2001) 2.07
Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst (2001) 2.06
Complications leading to surgery after breast implantation. N Engl J Med (1997) 2.05
Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut (2001) 2.05
Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol (1996) 2.01
Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause. J Clin Invest (1986) 2.01